Cytek Biosciences (CTKB) said late Wednesday it opened a new innovation center in Bellevue, Washington, relocating its previous Seattle-area operations to a dedicated facility focused on research and development, customer engagement and technical collaboration.
The new facility, where Cytek is the sole tenant, will consolidate training, customer demonstrations, and assembly and testing operations under one roof, the company said.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
Comments